IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 226 filers reported holding IMMUNOMEDICS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,582,000 | -70.9% | 18,606 | -87.9% | 0.01% | -70.6% |
| Q2 2020 | $5,428,000 | +689.0% | 153,137 | +199.2% | 0.02% | +466.7% |
| Q1 2020 | $688,000 | -30.4% | 51,178 | +9.8% | 0.00% | 0.0% |
| Q4 2019 | $988,000 | -7.1% | 46,594 | -42.0% | 0.00% | 0.0% |
| Q3 2019 | $1,063,000 | -1.6% | 80,319 | +3.0% | 0.00% | -25.0% |
| Q2 2019 | $1,080,000 | -24.1% | 77,980 | +5.1% | 0.00% | -20.0% |
| Q1 2019 | $1,422,000 | +712.6% | 74,162 | +778.7% | 0.01% | +400.0% |
| Q4 2018 | $175,000 | -13.4% | 8,440 | -11.8% | 0.00% | 0.0% |
| Q3 2018 | $202,000 | -84.9% | 9,574 | -83.1% | 0.00% | -80.0% |
| Q2 2018 | $1,339,000 | +1992.2% | 56,551 | +1191.4% | 0.01% | – |
| Q1 2018 | $64,000 | +42.2% | 4,379 | +57.0% | 0.00% | – |
| Q4 2017 | $45,000 | -2.2% | 2,790 | -15.9% | 0.00% | – |
| Q3 2017 | $46,000 | +253.8% | 3,318 | +128.7% | 0.00% | – |
| Q2 2017 | $13,000 | +160.0% | 1,451 | +73.8% | 0.00% | – |
| Q1 2017 | $5,000 | – | 835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |